2012-09-07 18:21:14 - Karo Bio and Pfizer Deal for RORgamma Modulators - Deal Analysis - a new market research report on companiesandmarkets.com

Karo Bio and Pfizer Deal for RORgamma Modulators - Deal Analysis from GlobalData - December 24, 2011 witnessed the commencement of the research collaboration agreement between Karo Bio, a Sweden-based company, and Pfizer, headquartered in the US for RORgamma modulators. This research collaboration is the second collaboration with Pfizer. The first collaboration agreement was signed in 2001 with Weyth, which was subsequently acquired by Pfizer in 2009, for the Liver X receptor inflammation program. Under the latest agreement, Pfizer will fund the research cost for the development of RORgamma modulators for the treatment of autoimmune diseases.

Report Scope

- The deal analysis tells about the rational behind the collaboration.
- The marketing rights of the developed products and the funding respossibility of the

 

 

research program.

Reasons to buy

- Provides insights about the autoimmune therapeutics landscape and guides for partneship rational.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.